This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Prospects From Examination of Recent Experience

George Gee Jackson, MD; Edith D. Stanley, MD

JAMA. 1976;235(25):2739-2742.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

CHEMOTHERAPEUTIC drugs to prevent and treat influenza would be of only academic interest if safe vaccines were always available, produced lasting or reasonably persistent immunity, and were used effectively. At present, neither the goals nor extent of use of immunoprophylaxis for influenza is adequate to produce any "herd immunity" or substantially interrupt virus transmission. Available vaccines induce a rise in serum antibody in approximately 85% of vaccinees, but produce respiratory secretory antibody in only a small percentage. Protection against influenza in the same year occurs in about 70% of vaccinees. When a major new antigenic strain of influenza virus appears, less vaccine is available, two or more injections may be required, and the production of immunity is less. The duration of immunity following killed-virus vaccines is limited to a few years, and there is uneasiness among biologists about the advisability of using defective live virus preparations that might produce latent . . . [Full Text PDF of this Article]

Author Affiliations
From the Section of Infectious Diseases, Department of Medicine, University of Illinois, Abraham Lincoln School of Medicine, Chicago.

Footnotes
Adapted from an address read before the Working Group on Pandemic Influenza (sponsored by the Sandoz Institute for Health and Socio-Economic Studies), Rougemont, Switzerland, Jan 26-28, 1976.

Reprint requests to Department of Medicine, The Abraham Lincoln School of Medicine, PO Box 6998, Chicago, IL 60680 (Dr Jackson).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?